Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: A population-based study

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 3, 2000, Pages 1340-1344

  Straub, R H ^a   Hense, H W ^b   Andus, T ^a   Scholmerich J ^a   Riegger, G A J ^a   Schunkert, H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CONJUGATED ESTROGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTRADIOL; ESTRIOL; ESTROGEN; INTERLEUKIN 6; PROGESTERONE;

ADRENERGIC SYSTEM; ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE; BODY FAT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HEART RATE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0034454417     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.3.6355     Document Type: Article

References (39)

1. New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: Roles of IL-6 and gp130
2. 17 beta-estradiol inhibits interleukin-6 production by bone marrow- derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens
3. Interleukin 6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits
4. Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways
5. Elevated levels of interleukin-6 in unstable angina
6. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease
7. Procoagulant and proinflammatory activity in acute coronary syndromes
8. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the Studies of Left Ventricular Dysfunction (SOLVD)
9. Circulating interleukin-6 in severe heart failure
10. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin- 6 is an important prognostic predictor in patients with congestive heart failure
11. Role of cytokines in inducing hyperlipidemia
12. Interleukirt-6 stimulates hepatic triglyceride secretion in rats
13. Immune-neuro-endocrine interactions
14. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo
15. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid
16. The differential effect of food intake and beta-adrenergic stimulation on adiposederived hormones and cytokines in man
17. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity
18. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: Possible link between endocrinosenescence and immunosenescence
19. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal
20. Down-modulation of interleukin-6 gene expression by 17β-estradiol in the absence of high affinity DNA binding by the estrogen receptor
21. 17β-Estradiol inhibits expression of human interleukin-6 promoter- reporter constructs by a receptor-dependent mechanism
22. Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors
23. Estradiol down-regulates LPS-induced cytokine production and NFβB activation in murine macrophages
24. Urinary oestrogen excretion after the menopause in relation to age and body mass
25. The relation among stress, adrenaline, interleukin 6 and acute phase proteins in the rat
26. Exercise stimulates interleukin-6 secretion: Inhibition by glucocorticoids and correlation with catecholamines
27. Association between a polymorphism in the G protein β3 subunit gene and lower renin and elevated diastolic blood pressure levels
28. Indices of relative weight and obesity
29. Induction of plasma interleukin-6 by circulating adrenaline in the rat
30. Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine
31. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: Synergism with IL-1β and TNFα
32. Central noradrenergic system modulates plasma interleukin-6 production by peripheral interleukin-1
33. Tonic neurogenic inhibition of interleukin-6 secretion from murine spleen caused by opioidergic transmission
34. Relation of obesity and diet to sympathetic nervous system activity
35. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure
36. IL-1 is expressed in human adrenal gland in vivo. Possible role in a local immuneadrenal axis
37. Atherosclerosis and the menopause
38. Premenopausal castration and documented coronary atherosclerosis
39. Estrogens and the aging process. The detection, prevention, and retardation of osteoporosis